Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Breast Cancer Res Treat ; 149(2): 449-60, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25555830

RESUMO

The aim of this study was to evaluate the effectiveness of an additional, individualized, multi-component complementary medicine treatment offered to breast cancer patients at the Merano Hospital (South Tyrol) on health-related quality of life compared to patients receiving usual care only. A randomized pragmatic trial with two parallel arms was performed. Women with confirmed diagnoses of breast cancer were randomized (stratified by usual care treatment) to receive individualized complementary medicine (CM group) or usual care alone (usual care group). Both groups were allowed to use conventional treatment for breast cancer. Primary endpoint was the breast cancer-related quality of life FACT-B score at 6 months. For statistical analysis, we used analysis of covariance (with factors treatment, stratum, and baseline FACT-B score) and imputed missing FACT-B scores at 6 months with regression-based multiple imputation. A total of 275 patients were randomized between April 2011 and March 2012 to the CM group (n = 136, 56.3 ± 10.9 years of age) or the usual care group (n = 139, 56.0 ± 11.0). After 6 months from randomization, adjusted means for health-related quality of life were higher in the CM group (FACT-B score 107.9; 95 % CI 104.1-111.7) compared to the usual care group (102.2; 98.5-105.9) with an adjusted FACT-B score difference between groups of 5.7 (2.6-8.7, p < 0.001). Thus, an additional individualized and complex complementary medicine intervention improved quality of life of breast cancer patients compared to usual care alone. Further studies evaluating specific effects of treatment components should follow to optimize the treatment of breast cancer patients.


Assuntos
Neoplasias da Mama/terapia , Terapias Complementares , Qualidade de Vida , Idoso , Neoplasias da Mama/diagnóstico , Terapia Combinada , Terapias Complementares/efeitos adversos , Terapias Complementares/métodos , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Estadiamento de Neoplasias , Fatores de Risco , Resultado do Tratamento
2.
Neuropsychiatr ; 23(1): 35-41, 2009.
Artigo em Alemão | MEDLINE | ID: mdl-19272290

RESUMO

Postpartum dysphoria (Baby Blues) is a puerperal-disease of mothers who have recently given birth; its prevalence in western industrialized countries ranges from 26 to 85% The baby-blues may begin during the first week after birth, lasts a few days and disappears without any medical treatment. Therefore there is still little research dealing with this phenomenon. The present study was carried out in Brixen, Italy, in the framework of the international Munich-Postpartum-Project and was done by means of a questionnaire. It showed that these women who had to face an insecure social environment after hospital discharge, had symptoms of a dysphoria. For that reason the Blues seems to be a phenomenon of socially distressed women.


Assuntos
Depressão Pós-Parto/psicologia , Meio Social , Apoio Social , Adulto , Ansiedade/diagnóstico , Ansiedade/psicologia , Áustria , Comparação Transcultural , Estudos Transversais , Depressão Pós-Parto/diagnóstico , Depressão Pós-Parto/epidemiologia , Depressão Pós-Parto/fisiopatologia , Emoções/fisiologia , Estrogênios/fisiologia , Feminino , Inquéritos Epidemiológicos , Humanos , Pessoa de Meia-Idade , Inventário de Personalidade , Progesterona/fisiologia , Fatores de Risco , Adulto Jovem
3.
J Med Case Rep ; 5: 316, 2011 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-21767367

RESUMO

INTRODUCTION: Well-documented cases of untreated cervical intra-epithelial dysplasia resulting in fatal progression of invasive cervical cancer are scarce because of a long pre-invasive state, the availability of cervical cytology screening programs, and the efficacy of the treatment of both pre-invasive and early-stage invasive lesions. CASE PRESENTATION: We present a well-documented case of a 29-year-old Caucasian woman who was found, through routine conventional cervical cytology screening, to have pathologic Papanicolaou (Pap) grade III D lesions (squamous cell abnormalities). She subsequently died as a result of human papillomavirus type 18-associated cervical cancer after she refused all recommended curative therapeutic procedures over a period of 13 years. CONCLUSION: This case clearly demonstrates a caveat against the promotion and use of complementary alternative medicine as pseudo-immunologic approaches outside evidence-based medicine paths. It also demonstrates the impact of the individualized demands in diagnosis, treatment and palliative care of patients with advanced cancer express their will to refuse evidence-based treatment recommendations.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA